Transmissible Spongiform Encephalopathies Advisory Committee
October 14, 2004 Meeting
Date and Time:
The meeting will be held on October 14, 2004, 8:00 a.m. to 5:30 p.m.
Location:
Hilton-Washington DC/Silver Spring, 8727 Colesville Road, Silver Spring, MD, 20910, 301-589-5200
Contact Persons:
William Freas, Ph.D., or Sheila D. Langford, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512392. Please call the Information Line for up-to-date information on this meeting.
Agenda:
On October 14, 2004, the Committee will hear updates on: USDA-licensed tests for the diagnosis of bovine spongiform encephalopathy (BSE) and other transmissible spongiform encephalopathies (TSE), review of the worldwide BSE situation, new FDA/CFSAN BSE-food safety rules, and labeling claims for TSE clearance studies for plasma derivative products. The Committee will then discuss and make recommendations regarding presumptive transfusion transmissions of variant Creutzfeldt Jakob Disease (vCJD) and current FDA-recommended safeguards.
Oral Presentations:
Between approximately 9:20 and 9:50 a.m., and 2:45 and 3:15 p.m. on October 14, 2004, oral presentations from the public will be scheduled. Those desiring to make formal oral presentations should notify the contact person before October 7, 2004.
|
